Keith W Pfeil
Insider
First SEC filing: Aug. 26, 2019 · Latest: Aug. 26, 2019
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | GMED | A | 100,000 | · | · | 100,000 Direct | · | Acquired | (price as of 2026-10-02) |
| July 18, 2025 | GMED | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 23, 2025 | GMED | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 10, 2025 | GMED | M | 8,334 | · | · | 833 Direct | -90.91% | Disposed | (price as of 2026-10-02) |
| Jan. 10, 2025 | GMED | M | 5,833 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 10, 2025 | GMED | S 10b5-1 | 1,666 | $89.17 | $148,557 | 0 Direct | -100.00% | Disposed | -15.2% (price as of 2026-10-02) |
| Jan. 10, 2025 | GMED | S 10b5-1 | 12,501 | $88.17 | $1,102,213 | 1,666 Direct | -88.24% | Disposed | -14.3% (price as of 2026-10-02) |
| Jan. 10, 2025 | GMED | M | 8,334 | $53.27 | $443,952 | 14,167 Direct | +142.88% | Acquired | 41.9% (price as of 2026-10-02) |
| Jan. 10, 2025 | GMED | M | 5,833 | $49.65 | $289,608 | 5,833 Direct | · | Acquired | 52.3% (price as of 2026-10-02) |
| Jan. 26, 2024 | GMED | A | 60,000 | · | · | 60,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Oct. 10, 2023 | GMED | A | 5,000 | · | · | 5,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 2, 2023 | GMED | M | 15,000 | · | · | 9,167 Direct | -62.07% | Disposed | (price as of 2026-10-02) |
| Feb. 2, 2023 | GMED | M | 14,167 | · | · | 5,833 Direct | -70.84% | Disposed | (price as of 2026-10-02) |
| Feb. 2, 2023 | GMED | S 10b5-1 | 29,167 | $77.57 | $2,262,484 | 0 Direct | -100.00% | Disposed | -2.5% (price as of 2026-10-02) |
| Feb. 2, 2023 | GMED | M | 15,000 | $53.27 | $799,050 | 29,167 Direct | +105.88% | Acquired | 41.9% (price as of 2026-10-02) |
| Feb. 2, 2023 | GMED | M | 14,167 | $49.65 | $703,392 | 14,167 Direct | · | Acquired | 52.3% (price as of 2026-10-02) |
| Jan. 26, 2023 | GMED | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 27, 2022 | GMED | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 19, 2021 | GMED | M | 0 | · | · | 24,167 Direct | 0.00% | Disposed | (price as of 2026-10-02) |
| Aug. 19, 2021 | GMED | M | 833 | · | · | 20,000 Direct | -4.00% | Disposed | (price as of 2026-10-02) |
| Aug. 19, 2021 | GMED | S 10b5-1 | 833 | $76.13 | $63,416 | 0 Direct | -100.00% | Disposed | -0.7% (price as of 2026-10-02) |
| Aug. 19, 2021 | GMED | M | 833 | $49.65 | $41,358 | 833 Direct | · | Acquired | 52.3% (price as of 2026-10-02) |
| Aug. 19, 2021 | GMED | M | 833 | · | · | 23,334 Direct | -3.45% | Disposed | (price as of 2026-10-02) |
| Aug. 19, 2021 | GMED | S 10b5-1 | 833 | $76.13 | $63,416 | 0 Direct | -100.00% | Disposed | -0.7% (price as of 2026-10-02) |
| Aug. 19, 2021 | GMED | M | 833 | $53.27 | $44,374 | 833 Direct | · | Acquired | 41.9% (price as of 2026-10-02) |
| Aug. 2, 2021 | GMED | M | 833 | · | · | 24,167 Direct | -3.33% | Disposed | (price as of 2026-10-02) |
| Aug. 2, 2021 | GMED | S 10b5-1 | 833 | $83.24 | $69,339 | 0 Direct | -100.00% | Disposed | -9.2% (price as of 2026-10-02) |
| Aug. 2, 2021 | GMED | M | 833 | $53.27 | $44,374 | 833 Direct | · | Acquired | 41.9% (price as of 2026-10-02) |
| July 19, 2021 | GMED | M | 834 | · | · | 20,833 Direct | -3.85% | Disposed | (price as of 2026-10-02) |
| July 19, 2021 | GMED | S 10b5-1 | 834 | $78.25 | $65,260 | 0 Direct | -100.00% | Disposed | -3.4% (price as of 2026-10-02) |
| July 19, 2021 | GMED | M | 834 | $49.65 | $41,408 | 834 Direct | · | Acquired | 52.3% (price as of 2026-10-02) |
| July 1, 2021 | GMED | M | 833 | · | · | 25,000 Direct | -3.22% | Disposed | (price as of 2026-10-02) |
| July 1, 2021 | GMED | S 10b5-1 | 833 | $77.43 | $64,499 | 0 Direct | -100.00% | Disposed | -2.4% (price as of 2026-10-02) |
| July 1, 2021 | GMED | M | 833 | $53.27 | $44,374 | 833 Direct | · | Acquired | 41.9% (price as of 2026-10-02) |
| June 25, 2021 | GMED | M | 14,167 | $53.27 | $754,676 | 14,167 Direct | · | Acquired | 41.9% (price as of 2026-10-02) |
| June 25, 2021 | GMED | S 10b5-1 | 27,479 | $75.04 | $2,062,024 | 0 Direct | -100.00% | Disposed | 0.7% (price as of 2026-10-02) |
| June 25, 2021 | GMED | M | 14,167 | · | · | 25,833 Direct | -35.42% | Disposed | (price as of 2026-10-02) |
| June 25, 2021 | GMED | M | 13,312 | · | · | 21,667 Direct | -38.06% | Disposed | (price as of 2026-10-02) |
| June 25, 2021 | GMED | M | 13,312 | $49.65 | $660,941 | 13,312 Direct | · | Acquired | 52.3% (price as of 2026-10-02) |
| May 5, 2021 | GMED | M | 5,021 | · | · | 34,979 Direct | -12.55% | Disposed | (price as of 2026-10-02) |
| May 5, 2021 | GMED | S 10b5-1 | 5,021 | $75.00 | $376,575 | 0 Direct | -100.00% | Disposed | 0.8% (price as of 2026-10-02) |
| May 5, 2021 | GMED | M | 5,021 | $49.65 | $249,293 | 5,021 Direct | · | Acquired | 52.3% (price as of 2026-10-02) |
| Jan. 14, 2021 | GMED | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 22, 2020 | GMED | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Sept. 3, 2019 | GMED | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 21, 2026 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $94.15 | Jan. 21, 2036 | 100,000 | Acquired |
| July 18, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $56.34 | July 18, 2035 | 40,000 | Acquired |
| Jan. 23, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $92.42 | Jan. 23, 2035 | 60,000 | Acquired |
| Jan. 10, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 8,334 | Disposed |
| Jan. 10, 2025 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49.65 | Sept. 3, 2029 | 5,833 | Disposed |
| Jan. 26, 2024 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.75 | Jan. 26, 2034 | 60,000 | Acquired |
| Oct. 10, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.02 | Sept. 1, 2033 | 5,000 | Acquired |
| Feb. 2, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 15,000 | Disposed |
| Feb. 2, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49.65 | Sept. 3, 2029 | 14,167 | Disposed |
| Jan. 26, 2023 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $75.18 | Jan. 26, 2033 | 40,000 | Acquired |
| Jan. 27, 2022 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $63.68 | Jan. 27, 2032 | 40,000 | Acquired |
| Aug. 19, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 0 | Disposed |
| Aug. 19, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | · | Sept. 3, 2029 | 833 | Disposed |
| Aug. 19, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 833 | Disposed |
| Aug. 2, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 833 | Disposed |
| July 19, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49.65 | Sept. 3, 2029 | 834 | Disposed |
| July 1, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 833 | Disposed |
| June 25, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 14,167 | Disposed |
| June 25, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49.65 | Sept. 3, 2029 | 13,312 | Disposed |
| May 5, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49.65 | Sept. 3, 2029 | 5,021 | Disposed |
| Jan. 14, 2021 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $65.05 | Jan. 14, 2031 | 40,000 | Acquired |
| Jan. 22, 2020 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $53.27 | Jan. 22, 2030 | 40,000 | Acquired |
| Sept. 3, 2019 | GMED | Stock Option (Right to Buy Class A Common Stock) | Class A Common Stock | $49.65 | Sept. 3, 2029 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Aug. 26, 2019 | GMED | No securities are beneficially owned | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $479,467 | $117,000 | · | · | $783,000 | · | $38,345 | $4,400,159 |
| 2024 | $463,555 | · | · | $1,258,665 | $605,454 | · | $35,604 | $2,363,278 |
| 2023 | $414,690 | $100,000 | · | $1,179,403 | $336,375 | · | $32,980 | $2,063,448 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.